Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Dr Akbar Waljee discusses findings from a cohort study investigating the risk of cancer recurrence or a new primary cancer in patients with IBD, rheumatoid arthritis, or psoriasis who received anti-TNFα therapy.

Episode metadata supplied by the publisher feed · Published Jan 31, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases

0:00 4:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 4 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on January 31, 2020.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!